DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Clinical Trial Management System (CTMS) Market Analysis by Type, By Delivery Mode, By Component, By End-user And Segment Forecasts to 2024" report to their offering.
The global Clinical Trial Management System (CTMS) market is expected to reach USD 2.2 billion by 2024.
Rising research activities and increasing complexity in data management for multiple verticals such as pharmaceutical and biotechnology are anticipated to present the clinical trial management system market with lucrative opportunities over the forecast period. These systems are capable for speeding up the research activity along with cost containment which is crucial for pharmaceutical companies that invest a lot on R&D innovation.
The present business scenario is witnessing rapid changes in the market place and consumer preferences are pushing the players to innovate and generate better performing products at a faster rate, in order to sustain the competition. Owing to the aforementioned reason, CTMS are designed in way that requires minimal documentation by clinical trial professionals avoids unnecessary & repeat testing and facilitates easy payment management. This at the end makes the whole process faster and reduces the time to market.
Asia Pacific is projected to drive the market growth and provide numerous opportunities to industry players. The efforts by government officials and research industry towards improving infrastructure, rising number of research studies and digitalization coupled with centralization of the management systems are promoting growth of CTMS market over the forecast period.
- PARAXEL International Corporation
- Oracle Corporation
- Medidata Solutions Inc.
- Forte Research Systems Inc.
- Clinical Data
- Guger Technologies
- eClinForce Inc.
Key Topics Covered:
1 Research Methodology
2 Executive Summary
3 Market Snapshot
4 Market Variables, Trends & Scope
5 Market Categorization 1: Type Estimates & Trend Analysis
6 Market Categorization 2: Delivery Mode Estimates & Trend Analysis
7 Market Categorization 3: Component Estimates & Trend Analysis
8 Market Categorization 4: End-user Estimates & Trend Analysis
9 Market Categorization 5: Regional Estimates & Trend Analysis, by Type, Delivery Mode, Component&End-users
10 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/5m37ml/clinical_trial